Trial NCT02553499

View at ClinicalTrials.gov 
Org. Study IDs: 1248-001
Secondary IDs: MK-1248-001

Last trial update was posted on 2019-11-04

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasms

Other Conditions

Advanced Solid Tumor

Stopping Reasons

Enrollment prematurely discontinued due to program prioritization & not due to any safety concerns.

Limitations And Caveats

Enrollment into this study was prematurely discontinued due to program prioritization and not related to any safety concerns.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID